MENS
MENS
NASDAQ · Biotechnology

Jyong Biotech Ltd

$2.15
+0.25 (+13.16%)
As of Mar 31, 10:11 PM ET ·
Financial Highlights (FY 2025)
Revenue
66.78M
Net Income
5.53M
Gross Margin
65.4%
Profit Margin
8.3%
Rev Growth
+15.6%
D/E Ratio
0.23
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 65.4% 65.4% 65.4%
Operating Margin 9.6% 10.5% 9.9%
Profit Margin 8.3% 7.9% 7.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 66.78M 62.47M 71.10M
Gross Profit 43.71M 40.88M 46.53M
Operating Income 6.44M 6.54M 7.01M
Net Income 5.53M 4.95M 5.20M
Gross Margin 65.4% 65.4% 65.4%
Operating Margin 9.6% 10.5% 9.9%
Profit Margin 8.3% 7.9% 7.3%
Rev Growth +15.6% -3.5% +12.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 18.44M 16.43M 20.60M
Total Equity 79.46M 76.73M 77.77M
D/E Ratio 0.23 0.21 0.26
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 7.58M 8.61M 8.78M
Free Cash Flow 4.38M 4.03M 6.15M